Partnerships for better health

To achieve SDG 3 - Health & Wellbeing, innovation is needed. And as trial is the mother of invention, partnerships are essential to future good health. A challenge and huge potential, tells public-private partnership NEXT at Responsible Pharma.

Try, try, and try again - the path to health is based on trials.

15.11.2017

CSR.dk

Modern drugs go through quite rigorous trials. Though trying new approaches is indeed a corner stone of medicine, nowadays trials are extensive and very thorough. As a result, new drugs can be quite hard to test and therefore approve. A true dilemma for modern pharma and health care, as new treatment option are also essential to our continued development of high quality care. 
 
“You can’t cut any corners in trials. But you can pave the way to optimise the conduct of trials to ensure that good innovations can join our toolkit as easily and quickly as possible,” says Britta Smedegaard Andersen, project director for NEXT, the National Experimental Therapy Partnership. At Responsible Pharma she tells more – see programme.
 
NEXT is a public-private partnership within clinical research, established in 2014, consisting of the regions of Denmark, ten pharmaceutical companies, associated partners and one GTS institute. NEXT aims to make Denmark a preferred country for early clinical testing of new drugs in patients. In particular, NEXT focuses on proof of concept trials, works to optimise all processes relating to the start-up and implementation of clinical trials, and optimises legal and statutory processes.
 
“Creating true partnerships always has its challenges, but NEXT is a really success as the partnership works focused around the common goal to attract more clinical research to Denmark. This brings new medicine to the Danish – and indeed global – patients”, Britta Smedegaard Andersen points out.
 
Good health – good business
NEXT facilitates national disease specific research networks with Danish hospital departments meaning that Denmark offers one single point of contact for inquiries of clinical research projects. The private partners from the life science sector can also use NEXT as means of to attract clinical trials, branding Denmark in the global competition also.
 
“I think most would be impressed and pleased to see, how diligently new drugs are tested. But we also know that time is really essential – there are lives to save, and suffering to prevent; So we strongly believe in creating the best environment for these trials, but of course also appreciate, that this knowhow and process are actually highly valued,” says Britta Smedegaard Andersen, calling it a true triple win.
 
Conducting the trials in Denmark has thus shown to also be a good driver for local job creation, thus also creating a positive feedback loop for even better and more efficient trials. “As said – you can’t cut any corners, but the partnership model and an eye on the ball ensures better health for all”, she concludes.
 
Read more about NEXT here – or a summary of the report on the economical value of clinical trials (underlining the value of partnerships) here.
 
At Responsible Pharma, NEXT takes the stage along Ferring, Novo Nordisk Foundation, LEO Pharma, and the European Health Futures Forum – while the Sustainability Science Centre of the University of Copenhagen, the Medicon Valley Alliance and Skandia hold workshops and breakouts at the Maersk Tower in Copenhagen. Read more.

Bureau Veritas

Sponseret

Understand Climate Footprint Calculations – LCA, EPD, PEF and the GHG Protocol Explained

CSR.dk

Jobopslag: Fagmedie eller jobportal – hvad virker bedst?

Relateret indhold

15.09.2025BSR

Sponseret

Partnering with Suppliers to Advance Human Rights Due Diligence

08.09.2025UN Global Compact Network Denmark

Sponseret

UNGA & Leaders Summit 2025

25.08.20253H Law

Sponseret

Den Grønne Lovguide: CO2-tal og klimadata – hvordan formidler man det juridisk korrekt?

21.08.20253H Law

Sponseret

Dokumentation af grønne påstande – hvad kræver loven?

20.08.2025CSR.dk

Strikkere sørger for kæmpe beløb til Unicef i Gaza

18.08.2025BSR

Sponseret

Developing Integrated Approaches to Human Rights, Climate, and Nature

15.08.20253H Law

Sponseret

Klimakompensation og markedsføring: En juridisk balancegang

07.08.20253H Law

Sponseret

Grønne udsagn og den konkrete vurdering

Hold dig opdateret med CSR.dk

Tilmeld dig nyhedsbrevet og følg med i alt som rører sig indenfor ESG og bæredygtig udvikling Nyhedsbrevet kommer kun to gange ugentligt. Herudover sender vi dig relevante temaer og spændede events.

Se flere temaer

Events

Se alle
DNV Business Assurance Denmark
Kursus
AQAP NATO Kvalitetsstandarder - grundkursus

Er din virksomhed leverandør til Forsvaret eller har I planer om at blive det? Hvis ja, vil du blive mødt af krav om bevis for efterlevelse af kravene i AQAP, som er NATOs standarder for kvalitetsstyring.

Dato

16.09.2025

Sted

Odense

DNV Business Assurance Denmark
Kursus
Kvalitetskultur

Et effektivt ledelsessystem er kernen i en effektiv virksomhed og driver virksomheden frem mod sine strategiske mål. Det effektive ledelsessystem bør derfor forholde sig til sine interessenters behov og forventninger, risici og muligheder, lovkrav og ikke mindst organisationens værdier og kultur.

Dato

16.09.2025

Sted

Odense

DNV Business Assurance Denmark
Kursus
AQAP NATO Kvalitetsstandarder - grundkursus

Er din virksomhed leverandør til Forsvaret eller har I planer om at blive det? Hvis ja, vil du blive mødt af krav om bevis for efterlevelse af kravene i AQAP, som er NATOs standarder for kvalitetsstyring.

Dato

16.09.2025

Sted

Frederik VI´s Hotel, Odense

DNV Business Assurance Denmark
Kursus
Auditorkursus i kvalitetsledelse

Formålet med kurset er at få et grundigt kendskab til de værktøjer og auditprincipper, der skal anvendes af auditorerne, for at virksomheden får det optimale udbytte af virksomhedens kvalitetsledelsessystem efter DS/EN ISO 9001:2015 og den interne audit.

Dato

16.09.2025

Sted

Odense

Beierholm
Webinar
ESG to the point: Udvidet producentansvar - hvordan indrapporterer I emballage?

Vi oplevede stor interesse for webinaret omkring det udvidet producentansvar for engangsemballage, hvorfor vi har valgt at gentage succesen, så endnu flere virksomheder kan blive klogere på de regler, virksomheden muligvis er omfattet af. Denne gang fortæller vi også, hvorfor det udvidet producentansvar er et godt startsted for en række yderligere værdiskabende ESG- tiltag. Ud over at emballage og affaldsprodukter er centrale i klimaregnskabets Scope 3 afdeling, så skabes der vigtige data til fokus på ecodesign og cirkularitet, som kan være med til at forme ledelsesbeslutninger om strategi og innovation. Disse elementer indgår naturligvis også i både CSRD og VSME rapporteringsstandarderne.

Dato

16.09.2025

Tid

08:15

Sted

Teams

Bureau Veritas
Webinar
Få indsigt i ISO 9001, ISO 14001 & ISO 45001

Deltag på dette webinar, hvis du ønsker et indblik i muligheder og fordele ved en certificering i ISO 9001, ISO 14001 eller ISO 45001.

Dato

16.09.2025

Tid

08:30

Sted

Online